Does δ-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?

European Journal of Human Genetics

Volumn 17, Issue 9, 2009, Pages 1148-1153

  Bauer, Ralf ^a   Hudson, Judith ^a   Müller, Harald D ^b   Sommer, Clemens ^b   Dekomien, Gabriele ^c   Bourke, John ^d   Routledge, Daniel ^a   Bushby, Kate ^a   Klepper, Jörg ^e   Straub, Volker ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d FREEMAN HOSPITAL   (United Kingdom)

^e KLINIKUM ASCHAFFENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DELTA SARCOGLYCAN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARDIOMYOPATHY; CHILD; CREATINE KINASE BLOOD LEVEL; EXON; FEMALE; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MISSENSE MUTATION; MUSCLE BIOPSY; PATHOGENESIS; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOPSY; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HEALTH; FEMALE; GENES, DOMINANT; HUMANS; MALE; MIDDLE AGED; MUSCLES; MUTATION, MISSENSE; MYOCARDIUM; PEDIGREE; SARCOGLYCANS; YOUNG ADULT;

EID: 69249211249     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.17     Document Type: Article

References (29)

1. Cohn RD, Campbell KP: Molecular basis of muscular dystrophies. Muscle Nerve 2000; 23: 1456-1471.
2. Hack AA, Lam MY, Cordier L et al: Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 2000; 113: 2535-2544.
3. Heydemann A, McNally EM: Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Trends Cardiovasc Med 2007; 17: 55-59.
4. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M: Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005; 32: 563-576.
5. Nigro V, de Sa Moreira E, Piluso G et al: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996; 14: 195-198.
6. Noguchi S, McNally EM, Ben Othmane K et al: Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995; 270: 819-822.
7. Bonnemann CG, Modi R, Noguchi S et al: Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995; 11: 266-273.
8. Zatz M, de Paula F, Starling A, Vainzof M: The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003; 13 532-544.
9. Zatz M, Vainzof M, Passos-Oueno MR: Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 2000; 13: 511-517.
10. Bushby KM: The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet 1999; 8: 1875-1882.
11. Politano L, Nigro V, Passamano L et al: Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 2001; 11: 178-185.
12. Hjermind LE, Vissing J, Asmus F et al: No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations. Eur J Neurol 2008; 15: 525-529.
13. Tsubata S, Bowles KR, Vatta M et al: Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106: 655-662.
14. Richardson P, McKenna W, Bristow M et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842.
15. Felker GM, Thompson RE, Hare JM et al: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
16. Grunig E, Tasman JA, Kucherer H, Franz W, Kubler W, Katus HA: Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31: 186-194.
17. Mestroni L, Rocco C, Gregori D et al: Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 1999; 34: 181-190.
18. Michels VV, Moll PP, Miller FA et al: The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82.
19. Franz WM, MuFler OJ, Katus HA: Cardiomyopathies: from genetics to the prospect of treatment. Lancet 2001; 358: 1627-1637.
20. Osterziel KJ, PerrMt A: Dilated cardiomyopathy: more genes means more phenotypes. Eur Heart J 2005; 26: 751-754.
21. Karkkainen S, Miettinen R, Tuomainen P et al: A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy. J Mol Med 2003; 81: 795-800.
22. Sylvius N, Duboscq-Bidot L, Bouchier C et al: Mutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 2003; 120 (Part A): 8-12.
23. Nigro V, Okazaki Y, Belsito A et al: Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 1997; 6: 601-607.
24. Coral-Vazquez R, Cohn RD, Moore SA et al: Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy. Cell 1999; 98: 465-474.
25. Dincer P, Bonnemann CG, Erdir Aker O et al: A homozygous nonsense mutation in δ-sarcoglycan exon 3 in a case of LGMD2F. Neuromuscul Disord 2000; 10: 247-250.
26. Gouveia TL, Kossugue PM, Paim JF et al: A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of δ-SG protein. J Mol Med 2007; 85: 415-420.
27. Shiga K, Yoshioka H, Masumiya T, Kimura I, Takeda S, Imamura M: Zeta-sarcoglycan is a functional homologue of gammasarcoglycan in the formation of the sarcoglycan complex. Exp Cell Res 2006; 312 2083-2092.
28. Heydemann A, Demonbreun A, Hadhazy M, Earley JU, McNally EM: Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes. Hum Mol Genet 2007; 16 355-363.
29. Zhu X, Hadhazy M, Groh ME, Wheeler MT, Wollmann R, McNally EM: Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly. J Biol Chem 2001; 276: 21785-21790.